Morenoborregaard2143

Our results show that electroporation, though lower in extraction yields than chemical lysis or mechanical disintegration, is in contrast to them a technique for largely debris-free extraction of proteins from microalgae, with no need for prior concentration or drying, with feasible growth regeneration, and with potential for simultaneous extraction of intracellular algal lipids into the supernatant.Polyaniline (PANi) is a conducting polymer which has been subject of intensive research on the exploitation of new products and applications. The main aim of the work is the development of a conductive bacterial cellulose (BC)-based material by enzymatic-assisted polymerization of aniline. For this, we study the role of carboxymethyl cellulose (CMC) as a template for the in situ polymerization of aniline. Bacterial cellulose was used as the supporting material for the entrapment of CMC and for the in situ oxidation reactions. The amount of CMC entrapped inside BC was optimized as well as the conditions for laccase-assisted oxidation of aniline. The new oligomers were evaluated by spectrometric techniques, namely 1H NMR and MALDI-TOF, and the functionalized BC surfaces were analyzed by thermogravimetric analysis (TGA), Fourier-transform infrared spectroscopy (FTIR), X-ray diffraction (XRD), scanning electron microscope (SEM), and reflectance spectrophotometry. The conductivity of the developed materials was evaluated using the four-probe methodology. The oligomers obtained after reaction in the presence of CMC as template display a similar structure as when the reaction is conducted only in BC. Though, after oxidation in the presence of this template, the amount of oligomers entrapped inside BC/CMC is considerably higher conferring to the material greater electrical conductivity and coloration. The use of CMC as a template for aniline oxidation on BC seems to be a promising and cheap strategy to improve the yield of functionalization and increment the properties of the materials, namely electrical conductivity and coloration.Highly efficient, well-dispersed PtRu alloy nanoparticles supported on high surface area microporous carbon (MPC) electrocatalysts, are prepared and tested for formic acid oxidation reaction (FAOR). The MPC is obtained by controlled carbonization of a zinc-benzenetricarboxylate metal-organic framework (Zn-BTC MOF) precursor at 950°C, and PtRu (30 wt.%) nanoparticles (NPs) are prepared and deposited via a polyol chemical reduction method. The structural and morphological characterization of the synthesized electrocatalysts is carried out using powder X-ray diffraction (PXRD), X-ray photoelectron spectroscopy (XPS), scanning electron microscopy (SEM), transmission electron microscopy (TEM), an energy dispersive X-ray (EDX) technique, and gas adsorption analysis (BET). The FAOR performance of the catalysts is investigated through cyclic voltammetry (CV), chronoamperometry (CA), and electrochemical impedance spectroscopy (EIS). A correlation between high electrochemical surface area (ECSA) and high FAOR performance of the catalysts is observed. Among the materials employed, Pt1Ru2/MPC 950 with a high electrochemical surface area (25.3 m2 g-1) consequently showed superior activity of the FAOR (I r = 9.50 mA cm-2 and J m = 2,403 mA mg Pt - 1 ) at room temperature, with improved tolerance and stability toward carbonaceous species. The superior electrochemical performance, and tolerance to CO-poisoning and long-term stability is attributed to the high surface area carbon support (1,455 m2 g-1) and high percentage loading of ruthenium (20 wt.%). The addition of Ru promotes the efficiency of electrocatalyst by offering FAOR via a bifunctional mechanism.Dyschromatosis universalis hereditaria (DUH) is a rare genodermatosis, which presents as hyper- and hypopigmented macules all over the body. Although a benign condition, rarely DUH is associated with abnormalities of dermal connective tissue, nerve, and systemic conditions. We report a case of DUH associated hypospadias and complicated with hydronephrosis that has not been described earlier.Introduction and background Isotretinoin is an oral medication used for the treatment of severe acne unresponsive to other medications. This drug is teratogenic and should be prescribed with appropriate caution in selected group of patients. The washout period for pregnancy post isotrenoin therapy has always been a topic of controversy. Several guidelines have recommended a wash out period of one month if pregnancy is planned in a patient being administered with the drug. Objective This article discusses the available evidence for different recommended wash out periods and addresses important clinical questions that arise. Methods Pubmed research was carried out to collect relevant data using the keywords isotretinoin, pregnancy, contraception, pharmacokinetics and guidelines. Conclusion Our research based on the published data concludes that a wash out period of 35 days post isotretinoin therapy is adequate in routine clinical practice.Gout is a metabolic disease that occurs either because of increased uric acid production or decreased uric acid secretion. It most commonly affects middle-aged to elderly men and postmenopausal women. Chronic tophaceous gout frequently occurs after 10 years or more of recurrent polyarticular gout. Gouty tophi are deposition of monosodium urate (MSU) crystals in and around joints as well as soft tissues. Darolutamide chemical structure We present a case of chronic tophaceous gout in a 21-year-old male, which occurred after 4 years of onset of gouty arthritis. The patient presented with tophaceous gout in four forms, that is, periarticular subcutaneous tophi, disseminated intradermal tophi, ulcerative form, and miliarial tophi along with multiple sinuses discharging chalky white material. The case was diagnosed as chronic tophaceous gout on the basis of raised serum uric acid, imprint smear showing needle-shaped crystals and negatively birefringent crystals on polarized microscopy. The case is interesting for varied morphological forms of tophaceous gout in a patient at an early age and shorter interval between onset of gouty arthritis and tophaceous gout.